KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Accumulated Expenses (2016 - 2025)

Cvs Health's Accumulated Expenses history spans 17 years, with the latest figure at $22.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 7.58% year-over-year to $22.4 billion, compared with a TTM value of $22.4 billion through Dec 2025, up 7.58%, and an annual FY2025 reading of $22.4 billion, up 7.58% over the prior year.
  • Accumulated Expenses for Q4 2025 was $22.4 billion at Cvs Health, down from $23.4 billion in the prior quarter.
  • The five-year high for Accumulated Expenses was $23.5 billion in Q4 2023, with the low at $14.3 billion in Q1 2021.
  • Average Accumulated Expenses over 5 years is $20.1 billion, with a median of $21.0 billion recorded in 2024.
  • Year-over-year, Accumulated Expenses rose 29.46% in 2023 and then fell 11.5% in 2024.
  • Tracing CVS's Accumulated Expenses over 5 years: stood at $17.7 billion in 2021, then increased by 6.08% to $18.7 billion in 2022, then grew by 25.45% to $23.5 billion in 2023, then dropped by 11.5% to $20.8 billion in 2024, then rose by 7.58% to $22.4 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Accumulated Expenses are $22.4 billion (Q4 2025), $23.4 billion (Q3 2025), and $23.1 billion (Q2 2025).